跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TAFAMIDIS AUROVITAS 20 MG CAPSULAS BLANDAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TAFAMIDIS AUROVITAS 20 MG CAPSULAS BLANDAS EFG
Approved
STANDARD
TAFAMIDIS AUROVITAS 20 MG CAPSULAS BLANDAS EFG
Aurovitas Spain, S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 10, 2026
Approval ID
177f343fce267568
Company
Aurovitas Spain, S.A.U.
Type
Standard
Approval Details
Approval Id
177f343fce267568
Drug Cima Aemps Name
TAFAMIDIS AUROVITAS 20 MG CAPSULAS BLANDAS EFG
Register Number
91571
Holder Company Name
Aurovitas Spain, S.A.U.
Marketing Company Name
Aurovitas Spain, S.A.U.
Authorization Date
2026-09-10
Dosage Form
CÁPSULA BLANDA
Dose
20 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Aurovitas Spain, S.A.U.
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 10, 2026
Approval ID
177f343fce267568
Type
Standard
Back to CIMA-AEMPS Approvals
